Home Compliance Lab Pays $3.6 Million to Settle Allegedly Redundant Drug Tests ComplianceFCANews Lab Pays $3.6 Million to Settle Allegedly Redundant Drug Tests October 12, 2022 36 Share FacebookLinkedinTwitter cawee | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Relator’s Claims Against Federal Grantees Survive Motion to Dismiss Compliance DOJ’s First Intervention in Cybersecurity FCA Qui Tam Case Signals Continued Cyber Enforcement Compliance Relator Alleged Violation of Statutes But Didn’t Adequately Plead False Certification